Improved Treatment Adherence
More patients in the PMA zeolite group completed the planned chemotherapy cycles than in the placebo group (p = 0.03) — among 120 patients on oxaliplatin-based chemotherapy.
Vitale, M.G. et al.: ZeOxaNMulti Trial. Molecules 2020, 25(10), 2297.
View publication (DOI)




